Abstract

The overuse of broad-spectrum antibiotics rapidly selects for dangerous multi-drug resistant bacterial pathogens. The landscape of antibiotic drug discovery is adapting to this wave of resistance with a movement towards narrow-spectrum, pathogen-targeted antibiotics that limit the emergence of new resistance. Sideromycins (siderophore-antibiotic conjugates) exploit essential iron acquisition pathways to achieve receptor-mediated cell entry where the spectrum of antibiotic activity is determined by highly selective cell surface siderophore receptors rather than the widely distributed and highly conserved antibacterial target. Sideromycins overwhelm traditional resistance mechanisms through high intracellular antibiotic concentrations and resistance adaptation renders pathogens avirulent. The timing is optimal to pursue sideromycins as pathogen-targeted antibiotics and chemical probes for rapid pathogen diagnostics.

Original languageEnglish
Title of host publicationTopics in Medicinal Chemistry
PublisherSpringer Verlag
Pages151-183
Number of pages33
DOIs
StatePublished - 2018

Publication series

NameTopics in Medicinal Chemistry
Volume26
ISSN (Print)1862-2461
ISSN (Electronic)1862-247X

Keywords

  • Albomycin
  • Antibiotic-delivery systems
  • Baulamycin
  • Enterobactin
  • Grisein
  • Microcin
  • Mycobactin
  • Pyoverdine
  • Salmycin
  • Sideromycin
  • Staphyloferrin
  • Tetroazolemycin
  • Trojan horse
  • Xenosiderophore

Fingerprint

Dive into the research topics of 'Sideromycins as Pathogen-Targeted Antibiotics'. Together they form a unique fingerprint.

Cite this